A case of scleromyxedema responding to lenalidomide and dexamethasone
نویسندگان
چکیده
The presence of corns can be considered as a marker for ulceration as the mechanical forces that cause corns and Calluses can also rupture portions of subcutaneous vascular plexus. In healthy patients this may be of minimal significance, but in patients with connective tissue disease it may herald extensive skin ulceration or vasculitis.[5] Thus, corns can be regarded as a sign of the onslaught brought about by the repetitive friction and shear. When the enormity of systemic involvement in SSc is considered, the association of corn may seem trivial. However, knowledge about its occurrence and prompt redressing will go a long way in alleviating the burden of pain and in avoiding more sinister complications such as ulceration.
منابع مشابه
Solitary lesion in papular elastorrhexis: A diagnostic challenge
1. Rongioletti F. Lichen myxedematosus (papular mucinosis): New concepts and perspectives for an old disease. Semin Cutan Med Surg 2006;25:100‐4. 2. Mateos M, Hernández M, Giraldo P, Rubia J, Arriba F, Corral L, et al. Lenalidomide plus Dexamethasone for High‐Risk Smoldering Multiple Myeloma. N Engl J Med 2013;369:438‐47. 3. Brunet‐Possenti F, Hermine O, Marinho E, Crickx B, Descamps V. Combina...
متن کاملLong-Term Therapy with Lenalidomide in a Patient with POEMS Syndrome.
Lenalidomide is an effective therapy against malignant plasma cells and a potent agent against proinflammatory and proangiogenic cytokines. The use of lenalidomide in POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein with plasma cells, skin changes) has been reported, but its benefit in long-term use is not well established. A 55-year-old man with POEMS and debilitating po...
متن کاملLenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.
This phase 1/2 study is the first prospective evaluation of lenalidomide-bortezomib-dexamethasone in front-line myeloma. Patients (N = 66) received 3-week cycles (n = 8) of bortezomib 1.0 or 1.3 mg/m(2) (days 1, 4, 8, 11), lenalidomide 15 to 25 mg (days 1-14), and dexamethasone 40 or 20 mg (days 1, 2, 4, 5, 8, 9, 11, 12). Responding patients proceeded to maintenance or transplantation. Phase 2 ...
متن کاملBrain Abscesses Caused by Nocardia paucivorans in a Multiple Myeloma Patient Treated with Lenalidomide and Dexamethasone: a Case Report and Review of Literature
We report the first case of multiple brain abscesses caused by Nocardia paucivorans in a patient suffering from multiple myeloma on treatment with lenalidomide and dexamethasone. N. paucivorans is a recently described species of the genus Nocardia, which is supposed to have a heightened neurotropism in cases of disseminated infection. Although nocardiosis itself is an uncommon infectious compli...
متن کاملLenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up
Chemotherapy in light chain amyloidosis aims to normalize the involved free light chain in serum, which leads to an improvement, or at least stabilization of organ function in most responding patients. We performed a prospective single center phase 2 trial with 50 untreated patients not eligible for high-dose treatment. The treatment schedule comprised 6 cycles of oral lenalidomide, melphalan a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 8 شماره
صفحات -
تاریخ انتشار 2017